AngioDynamics (NSDQ:ANGO) said today that put up $66 million for Eximo Medical and its B-Laser peripheral atherectomy device and cut its fiscal 2020 earnings outlook to allow for the cost of launching the Eximo product. Latham, N.Y-based AngioDynamics said the deal for Eximo involved $46 million in up-front cash and another $20 million in technical and […]
Eximo Medical’s hybrid catheter clears pivotal trial
Eximo Medical said a 20-patient pivotal trial in Europe, aimed at winning CE Mark approval there for its hybrid peripheral catheter, met its safety and efficacy endpoints. Rehovot, Israel-based Eximo’s device is designed to combine laser ablation with a blunt, bladed tip to clear partial or full peripheral blockages. The company said it’s pursuing the CE […]
Eximo Medical lands $1.6 Series A for Cathi hybrid catheter
Eximo Medical said today it closed a Series A funding round, bringing in $1.6 million to support its Cathi hybrid catheter. The Cathi catheter operates by combining laser ablation with a blunt, bladed tip, the company said, and is intended for use in treating peripheral artery disease. The round was led by Accelmed, with participation […]
MassDevice Network
@MassDevice
LinkedIn
YouTube